- Home
- GERN vs WERN Comparison
GERN vs WERN Comparison
Compare GERN & WERN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GERN
- WERN
- Stock Information
- Founded
- GERN 1990
- WERN 1956
- Country
- GERN United States
- WERN United States
- Employees
- GERN N/A
- WERN N/A
- Industry
- GERN Biotechnology: Pharmaceutical Preparations
- WERN Trucking Freight/Courier Services
- Sector
- GERN Health Care
- WERN Industrials
- Exchange
- GERN Nasdaq
- WERN Nasdaq
- Market Cap
- GERN 2.5B
- WERN 2.3B
- IPO Year
- GERN 1996
- WERN N/A
- Fundamental
- Price
- GERN $3.66
- WERN $39.62
- Analyst Decision
- GERN Strong Buy
- WERN Hold
- Analyst Count
- GERN 10
- WERN 16
- Target Price
- GERN $6.95
- WERN $37.31
- AVG Volume (30 Days)
- GERN 9.5M
- WERN 797.7K
- Earning Date
- GERN 11-07-2024
- WERN 10-29-2024
- Dividend Yield
- GERN N/A
- WERN 1.41%
- EPS Growth
- GERN N/A
- WERN N/A
- EPS
- GERN N/A
- WERN 0.73
- Revenue
- GERN $29,480,000.00
- WERN $3,097,524,000.00
- Revenue This Year
- GERN $30,930.80
- WERN N/A
- Revenue Next Year
- GERN $315.72
- WERN $4.13
- P/E Ratio
- GERN N/A
- WERN $54.23
- Revenue Growth
- GERN 9199.68
- WERN N/A
- 52 Week Low
- GERN $1.64
- WERN $33.12
- 52 Week High
- GERN $5.34
- WERN $43.26
- Technical
- Relative Strength Index (RSI)
- GERN 29.99
- WERN 54.45
- Support Level
- GERN $3.98
- WERN $37.04
- Resistance Level
- GERN $4.50
- WERN $42.48
- Average True Range (ATR)
- GERN 0.21
- WERN 1.29
- MACD
- GERN -0.05
- WERN 0.14
- Stochastic Oscillator
- GERN 3.45
- WERN 59.03
About GERN Geron Corporation
Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a rare blood cancer affecting bone marrow. The company earns revenue through collaboration agreements, milestones, royalties, and licensing arrangements. Geron possesses various rights to this drug. The company operates as a single segment being, the development of therapeutic products for oncology.
About WERN Werner Enterprises Inc.
Werner Enterprises Inc is a transportation and logistics company. The company has two reportable segments - TTS and Werner Logistics. It derives majority of its revenue from full-truckload transportation services and geographically from United States.